News Daily News New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery Michael O'Riordan September 24, 2024
News Daily News Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced Michael O'Riordan September 20, 2024
News Daily News Little Pre- and Postmarket Testing for Most Recalled CV Devices Michael O'Riordan September 16, 2024
News Daily News Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home Caitlin E. Cox September 16, 2024
News Daily News Liraglutide Helps Shed Weight in Young Children With Obesity Todd Neale September 13, 2024
News Conference News ESC 2024 Endometriosis and CV Risk: Link Needs Further Attention and Research Yael L. Maxwell September 12, 2024
News Daily News Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE Caitlin E. Cox September 12, 2024
News Conference News ESC 2024 STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines Todd Neale September 06, 2024
News Conference News ESC 2024 Complete Revascularization Better for Older STEMI Patients: Meta-analysis Todd Neale September 04, 2024
News Conference News ESC 2024 SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients Michael O'Riordan September 02, 2024
News Conference News ESC 2024 SHAM-PVI: Catheter Ablation Improves Objective Measure of AF Burden Todd Neale September 02, 2024
News Conference News ESC 2024 MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority Shelley Wood September 01, 2024
News Conference News ESC 2024 FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients Michael O'Riordan September 01, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Conference News ESC 2024 Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER Todd Neale August 31, 2024
News Conference News ESC 2024 ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients Michael O'Riordan August 30, 2024
News Conference News ESC 2024 HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM L.A. McKeown August 30, 2024